Page last updated: 2024-08-26

5-chloro-2'-deoxycytidine and Bowel Diseases, Inflammatory

5-chloro-2'-deoxycytidine has been researched along with Bowel Diseases, Inflammatory in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dedon, PC; Fox, JG; Kang, P; Knutson, CG; Korzenik, JR; Liberman, RG; Lu, K; Mangerich, A; Prestwich, EG; Raczynski, AR; Tannenbaum, SR; Wishnok, JS; Wogan, GN; Ye, W; Zeng, Y1

Other Studies

1 other study(ies) available for 5-chloro-2'-deoxycytidine and Bowel Diseases, Inflammatory

ArticleYear
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Jun-25, Volume: 110, Issue:26

    Topics: Acute-Phase Proteins; Animals; Biomarkers; Chemokines; Cytokines; Deoxycytidine; Disease Models, Animal; DNA Damage; DNA-Binding Proteins; Female; Helicobacter hepaticus; Helicobacter Infections; Humans; Immunity, Innate; Inflammatory Bowel Diseases; Male; Mice; Mice, Knockout; Tyrosine

2013